published in:: Journal of Health Economics, 2019, 65, 1 - 14
Health screening provides information on disease risk and diagnosis, but whether this promotes health is unclear. We estimate the impacts of the National Health Screening Program in Korea for diabetes, obesity, and hyperlipidemia. In this setting, information on disease risk and prompting for a secondary examination vary at different biomarker thresholds. We find evidence for increased diabetes medication and weight loss around the high risk threshold for diabetes, where information is combined with prompting for a secondary examination and subsequent medical treatment. However, we find no differences around other thresholds, where information is not combined with further intervention.
We use cookies to provide you with an optimal website experience. This includes cookies that are necessary for the operation of the site as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, you may not be able to use all of the site's functions.
Cookie settings
These necessary cookies are required to activate the core functionality of the website. An opt-out from these technologies is not available.
In order to further improve our offer and our website, we collect anonymous data for statistics and analyses. With the help of these cookies we can, for example, determine the number of visitors and the effect of certain pages on our website and optimize our content.